Retrospective Study
Copyright ©The Author(s) 2016.
World J Transplant. Sep 24, 2016; 6(3): 599-607
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.599
Figure 1
Figure 1 The impact of lab model for end-stage liver disease categories on 20 year survival. MELD: Model for end-stage liver disease; LT: Liver transplantation.
Figure 2
Figure 2 The impact of eurotransplant donor risk index categories on 20 year survival. LT: Liver transplantation; ET-DRI: Eurotransplant donor-risk-index.
Figure 3
Figure 3 The impact of donor age on 20-year survival. LT: Liver transplantation.
Figure 4
Figure 4 The influence of recipient-donor age match on 20-year survival. LT: Liver transplantation.
Figure 5
Figure 5 The impact of eurotransplant donor risk index categories on 20-year survival of recipients with cholestatic diseases, autoimmune hepatitis and acute liver failure. LT: Liver transplantation; ET-DRI: Eurotransplant donor-risk-index.
Figure 6
Figure 6 The impact of overweight (overweight, body-mass-index > 25) at time of liver transplantation on 20-year survival. LT: Liver transplantation; HBMI: High body mass index (> 25).